|
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
|
| Income Statement [Abstract] | ||
| Patient service revenues | $ 2,271,815us-gaap_HealthCareOrganizationPatientServiceRevenue | $ 2,114,098us-gaap_HealthCareOrganizationPatientServiceRevenue |
| Less: Provision for uncollectible accounts | (99,164)us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts | (83,197)us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts |
| Net patient service revenues | 2,172,651us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts | 2,030,901us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts |
| Capitated revenues | 850,515us-gaap_HealthCareOrganizationCapitationRevenue | 787,565us-gaap_HealthCareOrganizationCapitationRevenue |
| Other revenues | 264,799us-gaap_HealthCareOrganizationOtherRevenue | 224,310us-gaap_HealthCareOrganizationOtherRevenue |
| Total net revenues | 3,287,965us-gaap_HealthCareOrganizationRevenue | 3,042,776us-gaap_HealthCareOrganizationRevenue |
| Operating expenses and charges: | ||
| Patient care costs and other costs | 2,362,612dva_PatientCareCosts | 2,179,772dva_PatientCareCosts |
| General and administrative | 341,801us-gaap_GeneralAndAdministrativeExpense | 284,061us-gaap_GeneralAndAdministrativeExpense |
| Depreciation and amortization | 153,789us-gaap_DepreciationAndAmortization | 142,579us-gaap_DepreciationAndAmortization |
| Provision for uncollectible accounts | 1,827us-gaap_ProvisionForDoubtfulAccounts | 2,511us-gaap_ProvisionForDoubtfulAccounts |
| Equity investment income | (2,908)us-gaap_IncomeLossFromEquityMethodInvestments | (7,372)us-gaap_IncomeLossFromEquityMethodInvestments |
| Loss contingency accrual | 495,000us-gaap_LossContingencyLossInPeriod | |
| Total operating expenses and charges | 3,352,121us-gaap_CostsAndExpenses | 2,601,551us-gaap_CostsAndExpenses |
| Operating (loss) income | (64,156)us-gaap_OperatingIncomeLoss | 441,225us-gaap_OperatingIncomeLoss |
| Debt expense | (97,392)us-gaap_InterestAndDebtExpense | (106,335)us-gaap_InterestAndDebtExpense |
| Other (loss) income, net | (533)us-gaap_OtherNonoperatingIncomeExpense | 1,698us-gaap_OtherNonoperatingIncomeExpense |
| (Loss) income before income taxes | (162,081)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | 336,588us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Income tax (benefit) expense | (85,933)us-gaap_IncomeTaxExpenseBenefit | 124,851us-gaap_IncomeTaxExpenseBenefit |
| Net (loss) income | (76,148)us-gaap_ProfitLoss | 211,737us-gaap_ProfitLoss |
| Less: Net income attributable to noncontrolling interests | (34,469)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | (28,448)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest |
| Net (loss) income | $ (110,617)us-gaap_NetIncomeLoss | $ 183,289us-gaap_NetIncomeLoss |
| Earnings per share: | ||
| Basic net (loss) income per share attributable to DaVita HealthCare Partners Inc. | $ (0.52)us-gaap_EarningsPerShareBasic | $ 0.87us-gaap_EarningsPerShareBasic |
| Diluted net (loss) income per share attributable to DaVita HealthCare Partners Inc. | $ (0.52)us-gaap_EarningsPerShareDiluted | $ 0.85us-gaap_EarningsPerShareDiluted |
| Weighted average shares for earnings per share: | ||
| Basic | 213,387,253us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 211,375,232us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
| Diluted | 213,387,253us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 216,118,922us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
| X | ||||||||||
|
- Definition
Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs. No definition available.
|
| X | ||||||||||
|
- Definition
Total costs of sales and operating expenses for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized based on fees charged on a per capita basis. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized that is not otherwise disclosed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the provision for bad debts related to patient service revenue. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|